Denali Therapeutics
DNLI
#3996
Rank
A$4.19 B
Marketcap
A$26.42
Share price
-7.98%
Change (1 day)
17.25%
Change (1 year)

Revenue for Denali Therapeutics (DNLI)

Revenue in 2025 (TTM): N/A

a decrease over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Denali Therapeutics from 2017 to 2025

Annual revenue

Year Revenue Change
2025 N/A
2024 N/A-100%
2023 A$0.48 B204.38%
2022 A$0.15 B137.46%
2021 A$67.12 M-84.62%
2020 A$0.43 B1045.63%
2019 A$38.1 M-79.22%
2018 A$0.18 B
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Organovo
ONVO
A$0.2 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
A$31.77 MN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
A$1.49 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
A$0.93 BN/A Jersey